EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Genotype-guided pharmacotherapy: the challenges of integrating pharmacogenomic testing into routine healthcare with a focus on experiences at a single site

Larisa H Cavallari, Emily J Cicali, Madeline Norris, Khoa A Nguyen, Julio D Duarte

Expert Review of Clinical Pharmacology · 2025

DOI: 10.1080/17512433.2025.2568089 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Expert Review of Clinical Pharmacology, 2025. Verfasst von Larisa H Cavallari und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, College of Pharmacy, University of F…. Hauptthemen laut MEDLINE: Pharmacogenomic Testing, Pharmacogenetics. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 102 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Pharmacogenetic (PGx) testing remains widely underutilized despite strong evidence of genetic contributions to drug response and the availability of guidelines for integrating results into prescribing decisions. Challenges hindering PGx implementation include concerns about test reimbursement, knowledge gaps among patients and providers, and difficulty with effectively incorporating PGx data into the electronic health record (EHR). Our institution was an early adopter of PGx testing, with testing and clinical decision support available to guide multiple drug therapies, including clopidogrel, antidepressants, tacrolimus, and fluoropyrimidines. AREAS COVERED: This paper describes challenges our team and others have faced with PGx implementation and how we have addressed challenges common across implementations and those unique to specific gene-drug pairs. EXPERT OPINION: While we have demonstrated feasible solutions to overcome many implementation challenges, several key obstacles remain, including limited reimbursement for PGx testing as well as for pharmacist time in providing PGx consultations, challenges with EHR integration and portability of results, and demands for outcomes data. We anticipate broader implementation with legislative efforts to support reimbursement for testing and consultation. EHR vendors are also taking steps to better handle PGx data. Addressing genetic exceptionalism is particularly challenging but ultimately important for broad acceptance of PGx testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pharmacogenomic TestingPharmacogeneticsHumansElectronic Health RecordsGenotypeDecision Support Systems, ClinicalPharmacistsPrecision Medicine

Stichwörter der Autor:innen

Challengeselectronic health recordgene-drugimplementationpharmacogeneticsreimbursement

Autor:innen und Institutionen

  • Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, College of Pharmacy, University of Florida, Gainesville, FL, USA.

Zitieren

APA

Cavallari, L. H., Cicali, E. J., Norris, M., Nguyen, K. A., & Duarte, J. D. (2025). Genotype-guided pharmacotherapy: the challenges of integrating pharmacogenomic testing into routine healthcare with a focus on experiences at a single site. Expert Review of Clinical Pharmacology. https://doi.org/10.1080/17512433.2025.2568089

Vancouver

Cavallari LH, Cicali EJ, Norris M, Nguyen KA, Duarte JD. Genotype-guided pharmacotherapy: the challenges of integrating pharmacogenomic testing into routine healthcare with a focus on experiences at a single site. Expert Review of Clinical Pharmacology. 2025. doi:10.1080/17512433.2025.2568089

BibTeX
@article{Cavallari2025,
  author = {Cavallari, Larisa H and Cicali, Emily J and Norris, Madeline and Nguyen, Khoa A and Duarte, Julio D},
  title = {Genotype-guided pharmacotherapy: the challenges of integrating pharmacogenomic testing into routine healthcare with a focus on experiences at a single site},
  journal = {Expert Review of Clinical Pharmacology},
  year = {2025},
  doi = {10.1080/17512433.2025.2568089}
}
Kostenlos starten →